[PRESS RELEASE] – NEW YORK, Oct. 13, 2025 – Tilray Medical, a division of Tilray Brands Inc. and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and health care practitioners to make informed, individualized health decisions, transforming health care, has announced plans to expand its medical cannabis operations into Panama.
In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Global Inc., whose members have extensive experience in the distribution of medical devices since 2014. Together, Tilray and Top Tech, through their joint venture company, Solana Life Group, have received a medical cannabis license issued by the National Directorate of Pharmacy and Drugs in Panama, authorizing the cultivation, manufacturing, import, export, distribution and sale of medical cannabis in Panama.
With this joint venture partnership, Tilray Medical will leverage both its global expertise as well as the local expertise of Top Tech to facilitate the launch and ongoing distribution of medical cannabis products across Panama, thereby enhancing access for patients in need. Tilray is committed to supporting the Panamanian medical community by providing education, maintaining a reliable supply chain, and offering a comprehensive portfolio of cannabinoid-based therapies.
This partnership highlights Tilray’s dedication to patient-centric care worldwide and its objective to deliver safe, high-quality cannabis medicines tailored to individual patients’ requirements. Tilray Medical intends to collaborate closely with health care professionals, regulatory authorities and patient advocacy organizations in Panama to provide trusted therapeutic alternatives and uphold rigorous standards in medical cannabis.
This expansion represents a further progression in Tilray’s mission to support patients and health care practitioners globally, advancing health care through compassion and innovation.
